Ms. Kim Fookes

Kim Fookes has 29+ years of experience working in clinical research. Prior to being named the Global Head of DICT, Kim was responsible for all US clinical trial deliverables across Novartis’ portfolio, including early and late phase oncology and non-oncology.  She joined Novartis from AbbVie where she was the Head of Site Management & Monitoring, overseeing Global Site Management.  While at AbbVie, Kim also managed operations for the Global Medical Affairs’ Therapeutic Areas and US Medical Affairs.  Prior to AbbVie, she worked at Takeda, CROs, and Site Research Centers.

In her role as Global Head of DICT, she is working to imbed diversity across the R&D continuum so teams can consider diverse patient populations very early, including phase I trials.